ArticleInvestigative and clinical urology2020

A novel urinary mRNA signature using the droplet digital polymerase chain reaction platform improves discrimination between prostate cancer and benign prostatic hyperplasia within the prostate-specific antigen gray zone.

Ho Won Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.